Nonprescription Nasonex Gains UK Regulator’s Support
This article was originally published in The Pink Sheet
Executive Summary
The UK MHRA is accepting comments on its recommendation to allow pharmacy sales of nonprescription Nasonex Allergy Control (mometasone furoate/100 mcg).